[go: up one dir, main page]

DE69233035D1 - Gezielte punkt-mutagenese von dna - Google Patents

Gezielte punkt-mutagenese von dna

Info

Publication number
DE69233035D1
DE69233035D1 DE69233035T DE69233035T DE69233035D1 DE 69233035 D1 DE69233035 D1 DE 69233035D1 DE 69233035 T DE69233035 T DE 69233035T DE 69233035 T DE69233035 T DE 69233035T DE 69233035 D1 DE69233035 D1 DE 69233035D1
Authority
DE
Germany
Prior art keywords
dna
mutant
site
parental
circular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69233035T
Other languages
English (en)
Inventor
Jac A Nickoloff
Frank A Ray
Win P Deng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harvard University
Original Assignee
Harvard University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard University filed Critical Harvard University
Application granted granted Critical
Publication of DE69233035D1 publication Critical patent/DE69233035D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102Mutagenizing nucleic acids

Landscapes

  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
DE69233035T 1991-12-24 1992-12-17 Gezielte punkt-mutagenese von dna Expired - Lifetime DE69233035D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81358191A 1991-12-24 1991-12-24
PCT/US1992/011076 WO1993013216A1 (en) 1991-12-24 1992-12-17 Site-directed mutagenesis of dna

Publications (1)

Publication Number Publication Date
DE69233035D1 true DE69233035D1 (de) 2003-06-05

Family

ID=25212814

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69233035T Expired - Lifetime DE69233035D1 (de) 1991-12-24 1992-12-17 Gezielte punkt-mutagenese von dna

Country Status (7)

Country Link
US (1) US5354670A (de)
EP (1) EP0620858B1 (de)
JP (1) JP3398957B2 (de)
AT (1) ATE239089T1 (de)
CA (1) CA2126438C (de)
DE (1) DE69233035D1 (de)
WO (1) WO1993013216A1 (de)

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996039195A2 (en) * 1995-06-06 1996-12-12 Yale University Chemically modified oligonucleotide for site-directed mutagenesis
WO1997012993A1 (en) * 1995-10-02 1997-04-10 The Board Of Trustees Of The Leland Stanford Junior University Mismatch repair detection
US5780270A (en) * 1996-07-17 1998-07-14 Promega Corporation Site-specific mutagenesis and mutant selection utilizing antibiotic-resistant markers encoding gene products having altered substrate specificity
EP2202312B1 (de) * 1997-03-12 2016-01-06 Applied Biosystems, LLC DNA-Polymerase mit verbesserten etikettierten Nucleotideinbindungseigenschaften
CA2222993A1 (en) * 1998-02-04 1999-08-04 The Ontario Cancer Institute A method for using a ribosome-inactivating protein complex as a structural template and a molecular search engine in the design, construction and screening of combinatorial protein libraries
DE19826758C1 (de) * 1998-06-15 1999-10-21 Soft Gene Gmbh Darstellung von linearen kovalent geschlossenen DNA-Molekülen als Expressionskonstrukte
FR2789696A1 (fr) * 1999-02-12 2000-08-18 Biomethodes Procede de mutagenese d'un fragment d'acide nucleique par clonage et polymerisation-ligation
GB9906738D0 (en) * 1999-03-23 1999-05-19 Plant Bioscience Ltd Mutagenesis
JP3859947B2 (ja) * 2000-08-04 2006-12-20 独立行政法人理化学研究所 突然変異導入方法
US20020155439A1 (en) * 2000-12-04 2002-10-24 Ana Rodriguez Method for generating a library of mutant oligonucleotides using the linear cyclic amplification reaction
WO2002086088A2 (en) * 2001-04-24 2002-10-31 Li-Cor, Inc. Polymerases with charge-switch activity and methods of generating such polymerases
SE0102327D0 (sv) 2001-06-28 2001-06-28 Active Biotech Ab A novel engineered superantigen for human therapy
US20050042629A1 (en) 2002-09-13 2005-02-24 Applera Corporation Thermus scotoductus nucleic acid polymerases
US7052877B2 (en) 2001-11-30 2006-05-30 Applera Corporation Thermus brockianus nucleic acid polymerases
CA2494844C (en) 2002-08-12 2013-10-15 David Kirn Methods and compositions concerning poxviruses and cancer
WO2004016586A2 (en) * 2002-08-16 2004-02-26 Board Of Regents The University Of Texas System Compositions and methods related to flavivirus envelope protein domain iii antigens
DK1545587T3 (da) 2002-09-16 2011-05-09 Agennix Inc Lactoferrinsammensætninger og fremgangsmåder til behandling af diabetiske sår
US20100022414A1 (en) 2008-07-18 2010-01-28 Raindance Technologies, Inc. Droplet Libraries
CN100497382C (zh) 2003-04-02 2009-06-10 得克萨斯州大学系统董事会 突变型Bik的抗肿瘤效果
CA2526533C (en) * 2003-05-22 2014-01-14 Dow Agrosciences Llc High-throughput methods of screening dna for deletions and other mutations
GB0318110D0 (en) * 2003-08-01 2003-09-03 Isaeo Ltd Methods and kits for detecting an enzyme capable of modifying a nucleic acid
US7968287B2 (en) 2004-10-08 2011-06-28 Medical Research Council Harvard University In vitro evolution in microfluidic systems
GB0500417D0 (en) 2005-01-10 2005-02-16 Cambridge Antibody Tech Method of mutagenesis
PL1844144T3 (pl) * 2005-01-10 2010-09-30 Medimmune Ltd Sposób mutagenezy
US20070026012A1 (en) 2005-08-01 2007-02-01 Cornell Research Foundation, Inc. Compositions and methods for monitoring and altering protein folding and solubility
AU2006287441B2 (en) * 2005-09-07 2012-09-06 Sillajen Biotherapeutics, Inc. Systemic treatment of metastatic and/or systemically-disseminated cancers using GM-CSF-expressing poxviruses
US8980246B2 (en) 2005-09-07 2015-03-17 Sillajen Biotherapeutics, Inc. Oncolytic vaccinia virus cancer therapy
EP2402367A1 (de) * 2005-09-26 2012-01-04 Molecular Templates, Inc. Bibliothek aus Toxinmutanten und Verwendungsverfahren dafür
US8658608B2 (en) * 2005-11-23 2014-02-25 Yale University Modified triple-helix forming oligonucleotides for targeted mutagenesis
EP3913375A1 (de) 2006-01-11 2021-11-24 Bio-Rad Laboratories, Inc. Mikrofluidische vorrichtungen und verfahren zur verwendung bei der bildung und steuerung von nanoreaktoren
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
EP3031918B1 (de) 2006-05-11 2018-03-14 Raindance Technologies Inc. Mikrofluidische vorrichtungen
US8481023B2 (en) 2006-09-15 2013-07-09 Ottawa Hospital Research Institute Oncolytic rhabdovirus
BRPI0717474A2 (pt) 2006-10-20 2014-03-11 Arizona Board Of Regentes For And On Behalf Of Arizona State University Cianobactéria modificada
WO2008086529A2 (en) * 2007-01-11 2008-07-17 Yale University Compositions and methods for targeted inactivation of hiv cell surface receptors
WO2008097559A2 (en) 2007-02-06 2008-08-14 Brandeis University Manipulation of fluids and reactions in microfluidic systems
US8592221B2 (en) 2007-04-19 2013-11-26 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
US20100267147A1 (en) * 2007-04-25 2010-10-21 GM Biosciences, Inc. Site-directed mutagenesis in circular methylated dna
EP2183378A4 (de) * 2007-07-31 2010-09-22 Verenium Corp Massgeschneiderte kombinatorische mehrfachstellen-konstruktion
US12038438B2 (en) 2008-07-18 2024-07-16 Bio-Rad Laboratories, Inc. Enzyme quantification
WO2010111231A1 (en) 2009-03-23 2010-09-30 Raindance Technologies, Inc. Manipulation of microfluidic droplets
DK2477499T3 (en) 2009-09-14 2018-06-06 Sillajen Biotherapeutics Inc COMBINATION CANCER THERAPY WITH ONCOLYTIC VACCINIA VIRUS
MX337062B (es) 2009-12-10 2016-02-11 Ottawa Hospital Res Inst Rabdovirus oncolítico.
EP4484577A3 (de) 2010-02-12 2025-03-26 Bio-Rad Laboratories, Inc. Digitale analytanalyse
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
EP3447155A1 (de) 2010-09-30 2019-02-27 Raindance Technologies, Inc. Sandwichassays in tröpfchen
JP6121910B2 (ja) 2011-01-04 2017-04-26 シラジェン バイオセラピューティクス インコーポレイテッド 腫瘍溶解性ワクシニアウイルスの投与による腫瘍抗原に対する抗体の生成および腫瘍特異的補体依存性細胞傷害の生成
EP2673614B1 (de) 2011-02-11 2018-08-01 Raindance Technologies, Inc. Verfahren zur bildung gemischter tröpfchen
US9150852B2 (en) 2011-02-18 2015-10-06 Raindance Technologies, Inc. Compositions and methods for molecular labeling
WO2012167142A2 (en) 2011-06-02 2012-12-06 Raindance Technolgies, Inc. Enzyme quantification
WO2012167382A1 (en) 2011-06-08 2012-12-13 Children's Hospital Of Eastern Ontario Research Institute Inc. Compositions and methods for glioblastoma treatment
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
CA2848240C (en) 2011-09-16 2020-09-29 Lexogen Gmbh Nucleic acid transcription method
WO2013109950A1 (en) * 2012-01-20 2013-07-25 Kennesaw State University Research And Services Foundation Methods to mutate circular deoxyribonucleotides
AU2013232733B2 (en) 2012-03-13 2017-01-19 James Cook University Method for treating inflammation
WO2014071182A1 (en) 2012-11-01 2014-05-08 Massachusetts Institute Of Technology Directed evolution of synthetic gene cluster
JP2016513115A (ja) 2013-02-21 2016-05-12 チルドレンズ ホスピタル オブ イースタン オンタリオ リサーチ インスティチュート インコーポレイテッド ワクチン組成物
US10822395B2 (en) 2013-09-18 2020-11-03 James Cook University Modified anti-inflammatory proteins and method of use
CA2924130A1 (en) 2013-09-18 2015-03-26 James Cook University Anti-inflammatory proteins and methods of use
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US9944977B2 (en) 2013-12-12 2018-04-17 Raindance Technologies, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
CN108602729B (zh) 2015-07-13 2022-07-05 皮沃特生物公司 改良植物性状的方法及组合物
JP2018537119A (ja) 2015-10-05 2018-12-20 マサチューセッツ インスティテュート オブ テクノロジー リファクターされたnifクラスターを使用する窒素固定
US9975926B2 (en) 2015-12-08 2018-05-22 The United States of America, as Represented by the Secretary of Homeland Security Methods of making and using vaccines utilizing minicircle DNA expression vectors for production of foot-and-mouth-disease virus proteins and virus-like particles
KR20250071286A (ko) 2016-01-10 2025-05-21 네오티엑스 테라퓨틱스 엘티디. 면역강화제에 의해 증진되는 초항원 매개된 암 면역요법
CA3014792A1 (en) 2016-02-16 2017-08-24 Carnegie Mellon University Compositions for enhancing targeted gene editing and methods of use thereof
BR112019014378A2 (pt) 2017-01-12 2020-02-11 Pivot Bio, Inc. Métodos e composições para o aprimoramento de traços de plantas
WO2018187493A1 (en) 2017-04-04 2018-10-11 Yale University Compositions and methods for in utero delivery
WO2019084342A1 (en) 2017-10-25 2019-05-02 Pivot Bio, Inc. GENETIC TARGETS FOR TARGETING NITROGEN FIXATION FOR IMPROVING PLANT CHARACTERISTICS
CN120041362A (zh) 2017-10-25 2025-05-27 皮沃特生物股份有限公司 用于改良固氮的工程微生物的方法和组合物
EP3814302A4 (de) 2018-06-27 2022-06-29 Pivot Bio, Inc. Landwirtschaftliche zusammensetzungen mit remodellierten stickstofffixierenden mikroben
US20220017911A1 (en) 2018-12-21 2022-01-20 Pivot Bio, Inc. Methods, compositions, and media for improving plant traits
WO2020132737A2 (en) 2018-12-28 2020-07-02 Braskem S.A. Modulation of carbon flux through the meg and c3 pathways for the improved production of monoethylene glycol and c3 compounds
US12281299B2 (en) 2019-03-19 2025-04-22 Massachusetts Institute Of Technology Control of nitrogen fixation in rhizobia that associate with cereals
KR20220023756A (ko) 2019-04-24 2022-03-02 피벗 바이오, 인크. 식물 특성 향상을 위한 질소 고정 표적화용 유전자 표적
US20220213194A1 (en) 2019-05-15 2022-07-07 Neotx Therapeutics Ltd. Cancer treatment
CN114555833A (zh) * 2019-08-16 2022-05-27 分析生物科学有限公司 用于确定t细胞库的靶向杂交捕获方法
WO2021221690A1 (en) 2020-05-01 2021-11-04 Pivot Bio, Inc. Modified bacterial strains for improved fixation of nitrogen
CA3170369A1 (en) 2020-03-05 2022-04-14 Michal Shahar Methods and compositions for treating cancer with immune cells
CA3172637A1 (en) 2020-05-01 2021-11-04 Pivot Bio, Inc. Measurement of nitrogen fixation and incorporation
EP4143211A2 (de) 2020-05-01 2023-03-08 Pivot Bio, Inc. Modifizierte bakterienstämme zur verbesserten fixierung von stickstoff
BR112022022714A2 (pt) 2020-05-13 2023-03-28 Pivot Bio Inc Bactéria diazotrófica gram-positiva geneticamente modificada, composição microbiana, método para fornecer nitrogênio fixo a uma planta, gene glnr, proteína glnr, e, método para identificar reguladores de um operon nif
CN118302038A (zh) 2021-07-02 2024-07-05 皮沃特生物股份有限公司 用于改良固氮的基因工程化细菌菌株
WO2024137259A1 (en) 2022-12-23 2024-06-27 Pivot Bio, Inc. Combination of various nitrogen fixing bacteria with various biological products to achieve synergistic effects

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2092527T3 (es) * 1990-06-08 1996-12-01 Behringwerke Ag Metodo para la determinacion cuantitativa de secuencias de adn.
DE4024187A1 (de) * 1990-07-30 1992-02-06 Biotechnolog Forschung Gmbh Oligonucleotid-gerichtete mutagenese von plasmiden

Also Published As

Publication number Publication date
JP3398957B2 (ja) 2003-04-21
EP0620858A4 (en) 1997-05-07
ATE239089T1 (de) 2003-05-15
CA2126438C (en) 2003-12-02
JPH08500721A (ja) 1996-01-30
WO1993013216A1 (en) 1993-07-08
CA2126438A1 (en) 1993-07-08
US5354670A (en) 1994-10-11
EP0620858B1 (de) 2003-05-02
EP0620858A1 (de) 1994-10-26

Similar Documents

Publication Publication Date Title
DE69233035D1 (de) Gezielte punkt-mutagenese von dna
Schachat et al. Repetitive sequences in isolated Thomas circles from Drosophila melanogaster
EP0760002A4 (de) Die bestimmung von mutationen durch spaltung mit resolvase
MY133278A (en) Method of producing l-lysine by fermentation
DE69432818D1 (de) Enzym mit proteaseaktivität
DE3483839D1 (de) Verfahren zur herstellung von menschlichem tpa und expressionsvektoren dafuer.
KR950702240A (ko) 세제로의 이용을 위한 새로운 리파제 변형체
DE69203992D1 (de) Zusammensetzung und verfahren zur entfernung oder vermeidung von biobelag.
ATE31087T1 (de) Chemisches additions- oder substraktionsverfahren.
CA2256044A1 (en) Method and apparatus for automated design of complex structures using genetic programming
DE69636895D1 (de) Die Verwendung der 3'-wesentlichen Bearbeitungswirksamkeit von DNS-Polymerase
AR017023A1 (es) Tipeo genomico de adn metiltransferasa
EP1130090A3 (de) Screening-methode zur bereitstellung eines thermostabilen enzyms
DE59800946D1 (de) Verfahren zur herstellung von expandierbaren styrolpolymerisaten
ATE310079T1 (de) Enzymatische cofaktor-regeneration unter verwendung von pyridin-nucleotid transhydrogenase
DE50112684D1 (de) Zapfgasverfahren zur Gewinnung von elektrischer und thermischer Energie aus Biomassekesseln
EP0057976A3 (en) A process for cloning the gene coding for a thermostable alpha-amylase into escherichia coli and bacillus subtilis
DE69124549D1 (de) Kontrolle der Mikrosporogenese durch Verwendung von externinduzierbaren Promotorsequenzen
Reanney Genetic error and genome design
EP0818532A4 (de) Pflanzenpromoter und dessen verwendung zur genexpression
ATE170563T1 (de) Mikroorganismen zur stabilisierung von plasmiden
Nickoloff et al. Site-directed mutagenesis of DNA
Abdurashitov et al. BstF5I, an unusual isoschizomer of FokI
ES537637A0 (es) Un metodo de producir guanosina
Arber Cultural aspects of the theory of molecular evolution

Legal Events

Date Code Title Description
8332 No legal effect for de